ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Five plastic surgery startups selected for MTI/ASPS Plastic Surgery Accelerator competition finals

Arlington Heights, Ill, June 13, 2025 (GLOBE NEWSWIRE) -- Five startups advanced as finalists representing the ASPS Plastic Surgery track in the 2025 MedTech Innovator competition to champion technologies that improve results for patients. Each startup will participate in the comprehensive program, designed to help grow promising new companies focused on medical device, diagnostic and digital health technology.  

The plastic surgery track startups selected to advance in this joint effort between the American Society of Plastic Surgeons (ASPS) and MedTech Innovator (MTI) include MedCu Technologies, BRIJ Medical, InSoma Bio, Magsorbeo Biomedical and Regenyx Medical. The five finalists join a field of 60 additional startups from around the world that will compete for a share of $800,000 in funding awards during the four-month program.  

“We’re committed at ASPS to fostering innovation that improves the lives of our patients and advances the future of plastic surgery,” said Alan Matarasso, MD, FACS, president of The Plastic Surgery Foundation. “We’re helping bring forward technologies that have the potential to transform both reconstructive and aesthetic care by partnering with early-stage companies through the MTI/ASPS Accelerator. Supporting these innovators ensures our specialty continues to lead in delivering safe, effective, and cutting-edge solutions for patients.”  

There were 96 companies that applied for the plastic surgery track in the MTI competition this year, and 12 advanced to the live-pitch judging phase, where the top five were selected to represent ASPS and the plastic surgery track. Each of the five cohort participants from the MTI/ASPS Plastic Surgery Accelerator will be featured at Plastic Surgery The Meeting in New Orleans from October 9-12, and receive mentoring from ASPS surgeons and associated entrepreneurs. They will also participate in MedTech Innovator’s corporate mentorship program, where they will be matched with senior industry leaders to receive ongoing, in-depth, customized mentorship and support.  

This year’s event marks the fourth year of the ASPS/MTI partnership, but since the launch of MedTech Innovator in 2013, more than 500 companies have completed the program, resulting in more than 200 FDA approvals and clearances and $6.8 billion in funding. 

About the American Society of Plastic Surgeons 

The American Society of Plastic Surgeons (ASPS) is the largest organization of board-certified plastic surgeons in the world. Representing more than 11,000 physician members worldwide, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. Founded in 1931, the society represents physicians who have been certified by the American Board of Plastic Surgery or the Royal College of Physicians and Surgeons of Canada.  


Niccole Caan
American Society of Plastic Surgeons
8472283333
media@plasticsurgery.org

Recent Quotes

View More
Symbol Price Change (%)
AMZN  221.27
+0.00 (0.00%)
AAPL  271.84
+0.00 (0.00%)
AMD  198.11
+0.00 (0.00%)
BAC  54.55
+0.00 (0.00%)
GOOG  298.06
+0.00 (0.00%)
META  649.50
+0.00 (0.00%)
MSFT  476.12
+0.00 (0.00%)
NVDA  170.94
+0.00 (0.00%)
ORCL  178.46
+0.00 (0.00%)
TSLA  467.26
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.